TGFB1 and neoplasm: As mentioned in the Introduction, TGF-β has been demonstrated to evoke pathological EMT, i.e., a complex process inseparably associated with temporary loss of epithelial hallmarks and the acquisition of a highly motile mesenchymal phenotype necessary for aggressive tumour potential and malignant expansion [28,55].